310 related articles for article (PubMed ID: 30744931)
1. Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer's disease (1998-2018).
Mishra P; Kumar A; Panda G
Bioorg Med Chem; 2019 Mar; 27(6):895-930. PubMed ID: 30744931
[TBL] [Abstract][Full Text] [Related]
2. Rational drug design strategies for the development of promising multi-target directed indole hybrids as Anti-Alzheimer agents.
George N; Jawaid Akhtar M; Al Balushi KA; Alam Khan S
Bioorg Chem; 2022 Oct; 127():105941. PubMed ID: 35714473
[TBL] [Abstract][Full Text] [Related]
3. Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT
Więckowska A; Kołaczkowski M; Bucki A; Godyń J; Marcinkowska M; Więckowski K; Zaręba P; Siwek A; Kazek G; Głuch-Lutwin M; Mierzejewski P; Bienkowski P; Sienkiewicz-Jarosz H; Knez D; Wichur T; Gobec S; Malawska B
Eur J Med Chem; 2016 Nov; 124():63-81. PubMed ID: 27560283
[TBL] [Abstract][Full Text] [Related]
4. Tacrine-resveratrol fused hybrids as multi-target-directed ligands against Alzheimer's disease.
Jeřábek J; Uliassi E; Guidotti L; Korábečný J; Soukup O; Sepsova V; Hrabinova M; Kuča K; Bartolini M; Peña-Altamira LE; Petralla S; Monti B; Roberti M; Bolognesi ML
Eur J Med Chem; 2017 Feb; 127():250-262. PubMed ID: 28064079
[TBL] [Abstract][Full Text] [Related]
5. Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease.
Li Q; He S; Chen Y; Feng F; Qu W; Sun H
Eur J Med Chem; 2018 Oct; 158():463-477. PubMed ID: 30243151
[TBL] [Abstract][Full Text] [Related]
6. Recent Developments in Tacrine-based Hybrids as a Therapeutic Option for Alzheimer's Disease.
Yamali C; Donmez S
Mini Rev Med Chem; 2023; 23(7):869-880. PubMed ID: 36464869
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and evaluation of novel tacrine-coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease.
Xie SS; Wang XB; Li JY; Yang L; Kong LY
Eur J Med Chem; 2013 Jun; 64():540-53. PubMed ID: 23685572
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of 4-hydroxy-methylpiperidinyl-N-benzyl-acylarylhydrazone hybrids designed as novel multifunctional drug candidates for Alzheimer's disease.
Macedo Vaz S; de Freitas Silva M; Dos Reis Rosa Franco G; Jorge R Guimarães M; Motta R da Silva F; Gonçalves Castro N; Alvim Guedes I; Dardenne LE; Amaral Alves M; Garrett da Costa R; Beserra Pinheiro G; Germino Veras L; Renata Mortari M; Pruccoli L; Tarozzi A; Viegas C
Bioorg Med Chem; 2022 Oct; 71():116952. PubMed ID: 35930852
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and evaluation of novel multi-target-directed ligands for treatment of Alzheimer's disease based on coumarin and lipoic acid scaffolds.
Jalili-Baleh L; Forootanfar H; Küçükkılınç TT; Nadri H; Abdolahi Z; Ameri A; Jafari M; Ayazgok B; Baeeri M; Rahimifard M; Abbas Bukhari SN; Abdollahi M; Ganjali MR; Emami S; Khoobi M; Foroumadi A
Eur J Med Chem; 2018 May; 152():600-614. PubMed ID: 29763808
[TBL] [Abstract][Full Text] [Related]
10. Recent Developments on Multi-Target-Directed Tacrines for Alzheimer's Disease. I. The Pyranotacrines.
Romero A; Marco-Contelles J
Curr Top Med Chem; 2017; 17(31):3328-3335. PubMed ID: 29332586
[TBL] [Abstract][Full Text] [Related]
11. Multi-target-directed ligands for treating Alzheimer's disease: Butyrylcholinesterase inhibitors displaying antioxidant and neuroprotective activities.
Knez D; Coquelle N; Pišlar A; Žakelj S; Jukič M; Sova M; Mravljak J; Nachon F; Brazzolotto X; Kos J; Colletier JP; Gobec S
Eur J Med Chem; 2018 Aug; 156():598-617. PubMed ID: 30031971
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel series of 2-substituted benzo[d]oxazol-5-amine derivatives as multi-target directed ligands for the treatment of Alzheimer's disease.
Gutti G; Kakarla R; Kumar D; Beohar M; Ganeshpurkar A; Kumar A; Krishnamurthy S; Singh SK
Eur J Med Chem; 2019 Nov; 182():111613. PubMed ID: 31437780
[TBL] [Abstract][Full Text] [Related]
13. A review on flavonoid-based scaffolds as multi-target-directed ligands (MTDLs) for Alzheimer's disease.
Jalili-Baleh L; Babaei E; Abdpour S; Nasir Abbas Bukhari S; Foroumadi A; Ramazani A; Sharifzadeh M; Abdollahi M; Khoobi M
Eur J Med Chem; 2018 May; 152():570-589. PubMed ID: 29763806
[TBL] [Abstract][Full Text] [Related]
14. Quinolinetrione-tacrine hybrids as multi-target-directed ligands against Alzheimer's disease.
Uliassi E; Bergamini C; Rizzardi N; Naldi M; Cores Á; Bartolini M; Carlos Menéndez J; Bolognesi ML
Bioorg Med Chem; 2023 Aug; 91():117419. PubMed ID: 37487339
[TBL] [Abstract][Full Text] [Related]
15. Cystamine-tacrine dimer: a new multi-target-directed ligand as potential therapeutic agent for Alzheimer's disease treatment.
Minarini A; Milelli A; Tumiatti V; Rosini M; Simoni E; Bolognesi ML; Andrisano V; Bartolini M; Motori E; Angeloni C; Hrelia S
Neuropharmacology; 2012 Feb; 62(2):997-1003. PubMed ID: 22032870
[TBL] [Abstract][Full Text] [Related]
16. Novel tacrine-tryptophan hybrids: Multi-target directed ligands as potential treatment for Alzheimer's disease.
Chalupova K; Korabecny J; Bartolini M; Monti B; Lamba D; Caliandro R; Pesaresi A; Brazzolotto X; Gastellier AJ; Nachon F; Pejchal J; Jarosova M; Hepnarova V; Jun D; Hrabinova M; Dolezal R; Zdarova Karasova J; Mzik M; Kristofikova Z; Misik J; Muckova L; Jost P; Soukup O; Benkova M; Setnicka V; Habartova L; Chvojkova M; Kleteckova L; Vales K; Mezeiova E; Uliassi E; Valis M; Nepovimova E; Bolognesi ML; Kuca K
Eur J Med Chem; 2019 Apr; 168():491-514. PubMed ID: 30851693
[TBL] [Abstract][Full Text] [Related]
17. A novel class of multitarget anti-Alzheimer benzohomoadamantane‒chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors.
Pérez-Areales FJ; Turcu AL; Barniol-Xicota M; Pont C; Pivetta D; Espargaró A; Bartolini M; De Simone A; Andrisano V; Pérez B; Sabate R; Sureda FX; Vázquez S; Muñoz-Torrero D
Eur J Med Chem; 2019 Oct; 180():613-626. PubMed ID: 31351393
[TBL] [Abstract][Full Text] [Related]
18. Chemical and pharmacological studies on enantiomerically pure p-methoxytacripyrines, promising multi-target-directed ligands for the treatment of Alzheimer's disease.
Bartolini M; Pistolozzi M; Andrisano V; Egea J; López MG; Iriepa I; Moraleda I; Gálvez E; Marco-Contelles J; Samadi A
ChemMedChem; 2011 Nov; 6(11):1990-7. PubMed ID: 21990269
[No Abstract] [Full Text] [Related]
19. Design, synthesis and pharmacological evaluation of N-benzyl-piperidinyl-aryl-acylhydrazone derivatives as donepezil hybrids: Discovery of novel multi-target anti-alzheimer prototype drug candidates.
Dias Viegas FP; de Freitas Silva M; Divino da Rocha M; Castelli MR; Riquiel MM; Machado RP; Vaz SM; Simões de Lima LM; Mancini KC; Marques de Oliveira PC; Morais ÉP; Gontijo VS; da Silva FMR; D'Alincourt da Fonseca Peçanha D; Castro NG; Neves GA; Giusti-Paiva A; Vilela FC; Orlandi L; Camps I; Veloso MP; Leomil Coelho LF; Ionta M; Ferreira-Silva GÁ; Pereira RM; Dardenne LE; Guedes IA; de Oliveira Carneiro Junior W; Quaglio Bellozi PM; Pinheiro de Oliveira AC; Ferreira FF; Pruccoli L; Tarozzi A; Viegas C
Eur J Med Chem; 2018 Mar; 147():48-65. PubMed ID: 29421570
[TBL] [Abstract][Full Text] [Related]
20. Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids.
Bautista-Aguilera OM; Esteban G; Chioua M; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Soriano E; Samadi A; Unzeta M; Marco-Contelles J
Drug Des Devel Ther; 2014; 8():1893-910. PubMed ID: 25378907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]